Freschia Gonzales

Freschia Gonzales

Freschia is a News Writer for Key Media, contributing to Wealth Professional and Benefits and Pensions Monitor. She has also contributed to Australasian Lawyer and NZ Lawyer. She graduated with a Bachelor of Arts, majoring in International Studies from the University of San Jose Recoletos.

Starting her writing career in 2021, she has produced content for international audiences. In her spare time, Freschia critiques movies and series, follows musicals, and keeps up with pop culture.

LinkedIn | Email

Canadian DB plans stay flush as sponsors push ‘contribution holidays’

Surpluses buy cashflow relief but leave plans exposed to shocks and new mortality data

Canadian DB plans stay flush as sponsors push ‘contribution holidays’

Early retirement rush in Canada sparks fight over pension surplus and job security

Unions warn Canada’s early retirement push shifts risk onto workers’ pensions

Early retirement rush in Canada sparks fight over pension surplus and job security

Misaligned performance criteria quietly drain your pension plan’s potential

Clear criteria cut turnover by 40% and boost engagement 8.6x

Misaligned performance criteria quietly drain your pension plan’s potential

The quiet rise of wellness gadgets that promise less strain and more sleep

Blue light blocking devices now lead wellness tools, used by 35% of adults across global markets

The quiet rise of wellness gadgets that promise less strain and more sleep

Canadian pension plans keep funding edge despite volatile quarter

Aon tracker shows funded ratio dips to 111.4% as assets fall and discount rates rise

Canadian pension plans keep funding edge despite volatile quarter

AIMCo CIO bets on private credit despite benchmark miss

Pension manager holds 38% of assets in US as CIO leans into private credit

AIMCo CIO bets on private credit despite benchmark miss

England backs obesity drug for heart risk as rival pill ups the stakes

Novo and Lilly slash prices and push telehealth in the race for obesity drug dominance

England backs obesity drug for heart risk as rival pill ups the stakes

New lower-priced rival GLP‑1 pill wins FDA approval

FDA clears cheaper Eli Lilly pill, raising fresh questions about obesity drug coverage costs

New lower-priced rival GLP‑1 pill wins FDA approval

Pension manager posts 7.6% balanced fund return, misses benchmark

AIMCo assets climb to $194.7bn as balanced and total funds miss benchmarks

Pension manager posts 7.6% balanced fund return, misses benchmark

FSRA steps up enforcement as mortgage and insurance sanctions surge

Ontario watchdog boosts penalties and probes, putting suitability, and oversight under sharper glare

FSRA steps up enforcement as mortgage and insurance sanctions surge